NCT04566562View on ClinicalTrials.gov

Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

August 3, 2020

Primary Completion Date

January 30, 2024

Study Completion Date

February 29, 2024

Conditions
Neurocognitive DisordersPostoperative Cognitive Dysfunction
Interventions
DIAGNOSTIC_TEST

Brain Imaging

Magnetic Resonance Imaging (MRI) using diffusion weighted pseudo-continuous arterial spin labeling (DW-pCASL) .

DIAGNOSTIC_TEST

Cognitive Testing

Wide Range Assessment of Memory and Learning (WRAML 2) and Montreal Cognitive Assessment (MoCA)

DIAGNOSTIC_TEST

Blood Biomarkers

Inflammatory Markers

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT04566562 - Blood Brain Barrier Dysfunction and Postoperative Neurocognitive Disorders | Biotech Hunter | Biotech Hunter